← Scroll for more →
BeOne Medicines Ltd. (ONC)
Pharmaceutical Preparations
Latest Price
$371.56
TTM P/E
844.45
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
3.58
P/B Ratio
103.79
Valuation metrics
adjust assumptions →EPS: $0.19
Book value / share: $3.03
Formula: √(22.5 × EPS × BVPS)
Graham Number
$3.60
99% downside
EPS: $0.19
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$2.85
99% downside
Institutional Ownership
2.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 8.80M | $2.51B | 0.60% | +2.5K | 2026-06-30 |
| Primecap Management Co | 5.01M | $1.43B | 0.34% | +32.8K | 2026-06-30 |
| Capital International Investors | 4.21M | $1.20B | 0.29% | +51.5K | 2026-06-30 |
| FMR LLC | 2.48M | $706.0M | 0.17% | -1.22M | 2026-06-30 |
| Capital World Investors | 2.25M | $641.0M | 0.15% | +626.9K | 2026-06-30 |
| Citadel Advisors LLC | 1.45M | $412.0M | 0.10% | +393.3K | 2026-06-30 |
| Temasek Holdings (Private) Ltd | 845.7K | $241.0M | 0.06% | -16.9K | 2026-06-30 |
| Price T Rowe Associates Inc | 758.8K | $216.0M | 0.05% | +219.0K | 2026-06-30 |
| BlackRock, Inc. | 694.6K | $197.0M | 0.05% | +37.1K | 2026-06-30 |
| Millennium Management LLC | 568.3K | $161.0M | 0.04% | +363.5K | 2026-06-30 |